Your browser doesn't support javascript.
loading
The preliminary study of metallic stent implantation in combination with three-dimensional conformal radiation therapy in the treatment of hepatocellular carcinoma patients with portal vein tumor thrombus / 中华肝脏病杂志
Chinese Journal of Hepatology ; (12): 417-421, 2009.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-310070
Responsible library: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To study the clinical efficiency of metallic stent implantation in combination with three-dimensional conformal radiation therapy in the treatment of hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus.</p><p><b>METHODS</b>22 cases of HCC patients with portal vein tumor thrombus were devided into 2 groups 10 patients (group A) recieved stent implantation in combination with conformal radiation therapy, 12 patients (group B) recieved stent implantation and transcatheter arterial chemoembolization. The adverse reactions, and liver function before and after treatment were compared between the two groups. The stent patency rate at 4, 6 and 12 months and the survival rate at 3, 6 and 12 months were followed up. Comparison of liver function was analyzed by Wilcoxon signed rank test. Comparison of stent patency rate curves and survival curves was analyzed by Log rank test.</p><p><b>RESULTS</b>The portal vein catheterization was successful in all the patients. The stents were successfully implanted by transhepatic portal vein approach, and portal vein stenosis was re-opened. There was no abdominal hemorrhage in all the patients, but there were symptoms of abdominalgia, fever, nausea, vomiting and flatulence of varying degrees after interventional operation, and these symptoms were relieved by symptomatic treatment in one week. All patients in group A completed the treatment. I-II degree gastrointestinal tract reactions occurred in 3 cases, I-II degree myelosuppression occurred in 2 cases, and they were all completely relieved after treatment. The stent patency rate at 4, 6 and 12 months was 90%, 70%, 30% in group A; and 50%, 25% , 16.7% in group B (P < 0.05). The survival rate at 3, 6 and 12 months was 100%, 80% , 30% in group A and 91.7%, 41.7%, 16.7% in group B (P < 0.05).</p><p><b>CONCLUSION</b>Stent implantation combined with three-dimensional conformal radiation therapy is a good treatment for hepatocellular carcinoma with portal vein tumor thrombus and causes less damage to liver.</p>
Subject(s)
Full text: Available Database: WPRIM (Western Pacific) Main subject: Pathology / Portal Vein / Therapeutics / Diagnostic Imaging / Radiography / Stents / Survival Rate / Retrospective Studies / Follow-Up Studies / Treatment Outcome Type of study: Diagnostic study / Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Female / Humans / Male Language: Chinese Journal: Chinese Journal of Hepatology Year: 2009 Document type: Article
Full text: Available Database: WPRIM (Western Pacific) Main subject: Pathology / Portal Vein / Therapeutics / Diagnostic Imaging / Radiography / Stents / Survival Rate / Retrospective Studies / Follow-Up Studies / Treatment Outcome Type of study: Diagnostic study / Observational study / Prognostic study / Risk factors Limits: Adult / Aged / Female / Humans / Male Language: Chinese Journal: Chinese Journal of Hepatology Year: 2009 Document type: Article
...